Drug Type Small molecule drug |
Synonyms SU 5228 |
Target |
Mechanism EGFR antagonists(Epidermal growth factor receptor erbB1 antagonists), GRB2 inhibitors(Growth factor receptor-bound protein 2 inhibitors), RAS inhibitors(RAS type GTPase family inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | - | |
Neoplasms | Preclinical | US | - | |
Neoplasms | Preclinical | US | - |